Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
India’s Intas Pharmaceuticals will pay $740 million to buy the U.K. and Ireland business of Actavis Generics from Teva Pharmaceutical Industries. The European Union said Teva had to divest the business to win approval for its 2015 acquisition of Actavis Generics from Allergan. Intas says the new business will double its sales in Europe to $500 million annually and make it a top-20 player in generics.
This article has been sent to the following recipient: